Disc Medicine Inc reports results for the quarter ended in June - Earnings Summary

Disc Medicine

09/08/2024 14:31

* Disc Medicine Inc  IRON.OQ  reported a quarterly adjusted
loss
of $1.03​​ per share for the quarter ended in June, lower than
the same quarter last year, when the company reported EPS of -74
cents.  The mean expectation of nine analysts for the quarter
was for a loss of $1.11 per share. Wall Street expected
results to range from $-1.28 to $-1.02 per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Disc Medicine Inc's reported EPS for the quarter was a
loss of
$1.03​.
    * The company reported a quarterly loss of $26.35 million.
    * Disc Medicine Inc shares had fallen by 4.9% this
quarter and
lost 25.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 5% in
the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Disc Medicine Inc
is $70.00 
This summary was machine generated from LSEG data August 9 at
01:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -1.11          -1.03          Beat
 Mar. 31 2024      -1.00          -1.09          Missed
 Dec. 31 2023      -0.78          -0.90          Missed
 Sep. 30 2023      -0.80          -0.58          Beat